Nucleic Acid Therapeutics And Environmental Impact
By Tracy Humphries, Cytiva Marketing Leader, Nucleic Acid Therapeutics
Nucleic acid therapeutics are emerging as a pivotal part of the next generation of therapies. Modalities like viral vectors, RNA forms, plasmids, CAR-T, and cell therapies are becoming more prominent in the early stages of therapeutic development. Nucleic acid therapeutics, based on RNA or DNA, are opening up exciting new avenues of treatment for researchers. These therapies can be tailored to silence, express, and modify specific genes, offering a flexible and powerful approach to disease prevention and treatment. Continue reading to learn about the history of nucleic acid therapeutics as well as the environmental impact of manufacturing mRNA and oligonucleotides for therapeutics.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Advancing RNA? Subscribe today.